Further, we demonstrated that the therapeutic effect of GM-CSF was primarily mediated through the mobilization of CD11c+CD8α− DCs that could stimulate the expansion of Tregs in vivo and suppress autoimmune disease through increased IL-10 production10,11. This evidence concerns the gene CD8A and autoimmune disease.